BEMA Granisetron

Related by string. * Bema : BEMA TM Fentanyl . BEMA Fentanyl . migraine BEMA Triptan . BEMA TM Buprenorphine . BEMA Buprenorphine . product BEMA Buprenorphine . Bema Gold BGO . Bema Gold Corp. / granisetron : nausea vomiting BEMA Granisetron . granisetron formulated . Granisetron Hydrochloride Injection . containing granisetron . granisetron hydrochloride . Granisetron * *

Related by context. Frequent words. (Click for all words.) 68 Receives Orphan Drug Designation 67 KNS # 66 Panzem R 66 anticancer compound 66 liposomal formulation 66 Initiates Phase II 66 BEMA TM Fentanyl 66 Locteron ® 65 MKC# 65 TELINTRA 65 ZEGERID Capsules 65 Entereg R 65 Octreotide 65 Aerosurf 65 SILENOR TM 65 Onalta 65 Clonicel 65 Aurexis 65 Aloxi R 65 6R BH4 64 Phase III Clinical Trial 64 inhaled formulation 64 alvimopan 64 Urokinase 64 Presents Positive 64 QRxPharma 64 Pivotal Phase III 64 BEMA Buprenorphine 64 Tesetaxel 64 Fibrillex TM 64 R sorafenib tablets 64 refractory chronic lymphocytic 63 QNEXA 63 Phenoptin 63 Bicifadine 63 forodesine 63 PEG SN# 63 Alzhemed TM 63 TRANSDUR Sufentanil 63 Icatibant 63 KRN# 63 Ixempra 63 Onsolis 63 sodium Injection 63 Neurodex 63 pseudobulbar affect PBA 63 Daclizumab 63 ISTODAX 63 Zerenex 63 IND submission 63 subcutaneous formulation 63 injectable formulation 63 Omigard 63 Pivotal Phase 63 Ambrisentan 62 Factor VIIa 62 OMS# 62 CRTX 62 Drug Candidate 62 phase IIb clinical 62 Completes Enrollment 62 OMS#HP 62 Initiate Phase 62 rhThrombin 62 topical anti infective 62 BioGlue R 62 Phase 2b clinical trials 62 BrachySil 62 SILENOR ™ 62 Veronate 62 Kuvan R 62 Commences Phase 62 Soliris TM eculizumab 62 Testim R 62 Harbor BioSciences 62 Menerba 62 Anturol 62 tezampanel 62 ALN TTR# 62 elotuzumab 62 Initiates Phase 62 Crofelemer 62 TOCOSOL Paclitaxel 62 VALSTAR 62 orBec 62 Lubiprostone 62 Ferumoxytol 62 ONSOLIS 62 Argatroban 61 topical formulation 61 ALN TTR 61 Phase IIb trials 61 Zoraxel 61 Elevess 61 Exalgo 61 Genasense R oblimersen 61 Recombinant Human 61 INT# [002] 61 Application BLA 61 Excellagen 61 Phase 1b trial

Back to home page